Skip to main content
. 2016 Oct 26;57(4):513–523. doi: 10.1002/jcph.832

Figure 2.

Figure 2

Scatter plots of individual and median values for (A) maximum unbound serum evolocumab concentration (Cmax) and (B) area under the concentration‐time curve from time 0 to the time of the last quantifiable concentration (AUClast).

HHS Vulnerability Disclosure